Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV/AIDS Patients

1998109 citationsJournal Articlehybrid Open Access

Authors

John R. Graybill · Murphy Oil Corporation (United States)

José A. Vázquez · Wayne State University

Rabih O. Darouiche

R E Morhart

Deborah Greenspan · University of California, San Francisco

Carmelita U. Tuazon · George Washington University

L. Joseph Wheat · Urology of Indiana

John Carey

Abstract

Itraconazole oral solution is well tolerated and offers an alternative at least as effective as fluconazole in the treatment of oropharyngeal candidiasis.

Topics & Keywords

Pneumocystis jirovecii pneumonia detection and treatment HIV/AIDS oral health manifestations Antifungal resistance and susceptibility

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The American Journal of Medicine

Volume 104, Issue 1, pp. 33-39

DOI: 10.1016/s0002-9343(97)00307-0

Field-Weighted Citation Impact: 9.00